---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-036004"
form_type: "8-K"
ticker: "CTSO"
cik: "0001175151"
company_name: "Cytosorbents Corp"
filed_at: "2025-04-17T23:59:59+00:00"
generated_at: "2026-05-23T11:36:14.208303+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# CytoSorbents appoints Melanie Grossman as VP & Corp Controller; issues inducement options and RSUs

## Summary
- Appointment of Melanie Grossman as VP and Corporate Controller, effective April 14, 2025.
- Inducement grant includes 25,000 options at $0.99 exercise price, 10-year term, vesting 50% year 1 then 25% annually.
- Also granted 35,000 signing RSUs (change-of-control or 4-year cliff) and 35,000 change-of-control RSUs.
- Grossman brings 25 years of experience; previously SVP & Group Controller at Staffing 360 and auditor at Ernst & Young.

## SEC filing metadata
- accession: 0001104659-25-036004
- form_type: 8-K
- ticker: CTSO
- cik: 0001175151
- company_name: Cytosorbents Corp
- filed_at: 2025-04-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175151/000110465925036004/0001104659-25-036004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175151/000110465925036004/tm2512549d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-036004
- JSON: https://secwatch.observer/filing/0001104659-25-036004.json
- Plain text: https://secwatch.observer/filing/0001104659-25-036004.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.